April 3, 2017 Sophia Vida
Biotech & Pharma

Mylan Is Hit With A Racketeering Lawsuit Over EpiPen Price Increase

Many are probably thinking, wow, finally. When Mylan dramatically increased their price for the EpiPen, it had people all over up in arms over it. The huge list price increase of its anti-allergy device over the past decade finally got the company served with a class-action. The two-pack of the auto-injector device that is used … Continue reading “Mylan Is Hit With A Racketeering Lawsuit Over EpiPen Price Increase”